Am. J. Respir. Crit. Care Med., Volume 159, Number 3, March 1999, 829-833

Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome

ALIYA N. HUSAIN, MOMIN T. SIDDIQUI, EARLE W. HOLMES, ARCOT J. CHANDRASEKHAR, MARY MCCABE, RUTA RADVANY, and EDWARD R. GARRITY Jr.

Loyola Lung Transplant Program, Departments of Pathology and Internal Medicine, Loyola University Medical Center, Maywood, Illinois

Chronic rejection after lung transplantation, manifesting as bronchiolitis obliterans syndrome (BOS), has become the dominant challenge to long-term patient and graft survival. In order to elucidate risk factors for development of BOS we utilized the 1995 revision of the working formulation for the classification of lung allograft rejection (), and devised a quantitative method to retrospectively study lung transplant biopsies from all patients who survived at least 90 d. All transbronchial biopsies were regraded 0 to 4 for acute perivascular rejection and lymphocytic bronchitis/bronchiolitis (LBB), and the grades were totaled over a period of time to give two scores, respectively, for each patient. Also examined were timing of acute rejection and LBB episodes and decreased immunosuppression defined as two or more cyclosporine A levels < 200 ng/ml. Sixty-six patients with BOS and 68 with no BOS (NBOS) satisfied our criteria for inclusion in the study. Demographics including age, sex, and primary diagnoses were similar. The mean perivascular score for BOS was 6.2 over a mean follow-up of 822 d (range, 113 to 2,146) compared with 3.2 for NBOS over 550 d (range, 97 to 1,734) mean follow-up. Airway scores were 5.3 and 1.7, respectively, for the same follow-up periods. There was no correlation between length of follow-up and rejection or LBB scores, although mean length of follow-up for the two groups was significantly different. Late acute rejection and LBB were significantly associated with BOS as was decreased immunosuppression. In addition to perivascular rejection, LBB, late acute rejection, and decreased immunosuppression are significant risk factors for the development of BOS. Analysis of the current data leads us to believe that LBB, in the absence of infection, is in fact a manifestation of acute rejection, with similar implications for graft function as acute perivascular rejection.

This article has been cited by other articles:

				B. Skawran, M. Dierich, D. Steinemann, J. Hohlfeld, A. Haverich, B. Schlegelberger, T. Welte, and N. von Neuhoff Bronchial epithelial cells as a new source for differential transcriptome analysis after lung transplantation Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 715 - 721. [Abstract] [Full Text] [PDF]

				J. B. Orens and E. R. Garrity Jr. General Overview of Lung Transplantation and Review of Organ Allocation Proceedings of the ATS, January 15, 2009; 6(1): 13 - 19. [Abstract] [Full Text] [PDF]

				J. A. Belperio, S. S. Weigt, M. C. Fishbein, and J. P. Lynch III Chronic Lung Allograft Rejection: Mechanisms and Therapy Proceedings of the ATS, January 15, 2009; 6(1): 108 - 121. [Abstract] [Full Text] [PDF]

				L. Jarvinen, L. Badri, S. Wettlaufer, T. Ohtsuka, T. J. Standiford, G. B. Toews, D. J. Pinsky, M. Peters-Golden, and V. N. Lama Lung Resident Mesenchymal Stem Cells Isolated from Human Lung Allografts Inhibit T Cell Proliferation via a Soluble Mediator J. Immunol., September 15, 2008; 181(6): 4389 - 4396. [Abstract] [Full Text] [PDF]

				R. L. Anderson, P. S. Hiemstra, C. Ward, I. A. Forrest, D. Murphy, D. Proud, J. Lordan, P. A. Corris, and A. J. Fisher Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Eur. Respir. J., September 1, 2008; 32(3): 670 - 677. [Abstract] [Full Text] [PDF]

				A. R. Glanville, C. L. Aboyoun, A. Havryk, M. Plit, S. Rainer, and M. A. Malouf Severity of Lymphocytic Bronchiolitis Predicts Long-Term Outcome after Lung Transplantation Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1033 - 1040. [Abstract] [Full Text] [PDF]

				J. F. McDyer Human and Murine Obliterative Bronchiolitis in Transplant Proceedings of the ATS, January 1, 2007; 4(1): 37 - 43. [Abstract] [Full Text] [PDF]

				J. D. Lande, J. Patil, N. Li, T. R. Berryman, R. A. King, and M. I. Hertz Novel Insights into Lung Transplant Rejection by Microarray Analysis Proceedings of the ATS, January 1, 2007; 4(1): 44 - 51. [Abstract] [Full Text] [PDF]

				H. Liu, L. Liu, B. S. Fletcher, and G. A. Visner Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis FASEB J, November 1, 2006; 20(13): 2384 - 2386. [Abstract] [Full Text] [PDF]

				L. P. Nicod Mechanisms of airway obliteration after lung transplantation. Proceedings of the ATS, July 1, 2006; 3(5): 444 - 449. [Abstract] [Full Text] [PDF]

				K. A. Barbour, J. A. Blumenthal, and S. M. Palmer Psychosocial Issues in the Assessment and Management of Patients Undergoing Lung Transplantation Chest, May 1, 2006; 129(5): 1367 - 1374. [Abstract] [Full Text] [PDF]

				D. S. Wilkes, T. M. Egan, and H. Y. Reynolds Lung Transplantation: Opportunities for Research and Clinical Advancement Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955. [Abstract] [Full Text] [PDF]

				M. Tamm, C. L. Aboyoun, P. N. Chhajed, S. Rainer, M. A. Malouf, and A. R. Glanville Treated Cytomegalovirus Pneumonia Is Not Associated with Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1120 - 1123. [Abstract] [Full Text] [PDF]

				A. P. Khalifah, R. R. Hachem, M. M. Chakinala, K. B. Schechtman, G. A. Patterson, D. P. Schuster, T. Mohanakumar, E. P. Trulock, and M. J. Walter Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 181 - 187. [Abstract] [Full Text] [PDF]

				T.E. Corcoran, G.C. Smaldone, J.H. Dauber, D.A. Smith, K.R. McCurry, G.J. Burckart, A. Zeevi, B.P. Griffith, and A.T. Iacono Preservation of post-transplant lung function with aerosol cyclosporin Eur. Respir. J., March 1, 2004; 23(3): 378 - 383. [Abstract] [Full Text] [PDF]

				C. L. Lau, G. A. Patterson, and S. M. Palmer Critical Care Aspects of Lung Transplantation J Intensive Care Med, March 1, 2004; 19(2): 83 - 104. [Abstract] [PDF]

				A. Boehler and M. Estenne Post-transplant bronchiolitis obliterans Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018. [Abstract] [Full Text] [PDF]

				C.L. Lau and G.A. Patterson Current status of lung transplantation Eur. Respir. J., November 16, 2003; 22(47_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]

				V. J. Gimino, J. D. Lande, T. R. Berryman, R. A. King, and M. I. Hertz Gene Expression Profiling of Bronchoalveolar Lavage Cells in Acute Lung Rejection Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1237 - 1242. [Abstract] [Full Text] [PDF]

				J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection J. Immunol., November 1, 2003; 171(9): 4844 - 4852. [Abstract] [Full Text] [PDF]

				J. A. Belperio Paying a Toll for Acute Lung Allograft Rejection Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 623 - 624. [Full Text] [PDF]

				W. Chalermskulrat, I. P. Neuringer, J. L. Schmitz, D. J. Catellier, M. J. Gurka, S. H. Randell, and R. M. Aris Human Leukocyte Antigen Mismatches Predispose to the Severity of Bronchiolitis Obliterans Syndrome After Lung Transplantation Chest, June 1, 2003; 123(6): 1825 - 1831. [Abstract] [Full Text] [PDF]

				D. Hadjiliadis, R. D. Davis, and S. M. Palmer Is Transplant Operation Important in Determining Posttransplant Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients? Chest, October 1, 2002; 122(4): 1168 - 1175. [Abstract] [Full Text] [PDF]

				A. De SOYZA, A. J. FISHER, T. SMALL, and P. A. CORRIS Inhaled Corticosteroids and the Treatment of Lymphocytic Bronchiolitis Following Lung Transplantation Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1209 - 1212. [Abstract] [Full Text] [PDF]

				C. L. ABOYOUN, M. TAMM, P. N. CHHAJED, P. HOPKINS, M. A. MALOUF, S. RAINER, and A. R. GLANVILLE Diagnostic Value of Follow-up Transbronchial Lung Biopsy after Lung Rejection Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 460 - 463. [Abstract] [Full Text] [PDF]

				L. L. SCHULMAN, A. D. WEINBERG, C. C. McGREGOR, N. M. SUCIU-FOCA, and S. ITESCU Influence of Donor and Recipient HLA Locus Mismatching on Development of Obliterative Bronchiolitis after Lung Transplantation Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 437 - 442. [Abstract] [Full Text]

				M. REYNAUD-GAUBERT, P. THOMAS, M. BADIER, P. CAU, R. GIUDICELLI, and P. FUENTES Early Detection of Airway Involvement in Obliterative Bronchiolitis after Lung Transplantation . Functional and Bronchoalveolar Lavage Cell Findings Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1924 - 1929. [Abstract] [Full Text]

				J. W. K. van den BERG, A. GEERTSMA, W. van der BIJ, G. H. KOËTER, W. J. de BOER, D. S. POSTMA, and E. M. ten VERGERT Bronchiolitis Obliterans Syndrome after Lung Transplantation and Health-related Quality of Life Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1937 - 1941. [Abstract] [Full Text]